The identification of disease-associated genes has recently gathered much attention for uncovering disease complex mechanisms that could lead to new insights into the treatment of diseases.
Introduction
One of the most important challenges in disease treatment is the identification of causing genes that help us to design medical protocols. Genome-Wide Association Studies (GWAS) are new techniques for the identification of chromosomal intervals containing suspected disease related genes. These studies search for the genomes of single nucleotide polymorphisms (SNPs) that are not rare. However GWAS studies are not very accurate for detecting the exact gene related to a disease because they suggest hundreds or thousands of genes. Investigating all the genes suggested by GWAS in order to find the desired gene using experimental methods is very expensive and time consuming. Computational methods prioritize these genes and help us to focus on a smaller set of genes. For this purpose, computational methods utilize disease genes that are suggested experimentally as seed genes and prognosticate candidate genes for further studies. They use various data to solve the problem and some of them compose multiple data source information.
Related genes for the same or a homologous disease tend to have interactions with each other in the PPI network (1).
So the protein-protein interaction (PPI) network has become one of the most powerful sources in these studies, and this information has recently been provided in network structures. Integrating the PPI network with other biological data may lead to the discovery of new disease-causing genes. Some studies use local features of the PPI network, such as molecular triangulation (2), shortest path (SP) (3), and direct neighbors (4) to identify candidate genes.
Some other studies such as Random Walk with Restart (RWR) (5) and Network Propagation (NP) (6) relay on global network information. The results of local algorithms are more vulnerable because they do not consider indirect functional relationships and so only consider direct interactions (7). On the other hand, global algorithms rely on the overall relationship between the disease gene and the other genes of the PPI network. Although they do not consider genes with poor connections and outliers, they have displayed a better performance than local methods (8).
Genes scores calculation (NRSSPrioritize steps)
We applied NP, RWR, and SP algorithms separately on the PPI network to rank genes. Also, we employed disease similarity information in our scoring. The Dijkstra (19) algorithm was used to calculate the lengths and weight of shortest paths between the seed genes and the other genes. Then we divided the median of the weights of the shortest paths to the seeds to the average of the shortest paths length for each non-seed node. Obviously, a gene with a higher shortest path weight median and a smaller average length is more likely to be associated with disease (20) .
RWR calculates the proximity between nodes in the network (5). It repeatedly studies the global structure of the PPI network to approximate the relationship rate between nodes. RWR starts with a seed gene. In each step, it is faced with two choices; going to a neighbor of the current node or moving to one of the seed genes. It calculates node scores according to the following equation:
Here is the adjacency matrix in which its columns are normalized. 0 is a probability vector of the nodes at the first step. We assigned equal values to seed genes, and other gene probabilities are set to zero. represents a probability of all the nodes at step . Also, ∝ is a fixed parameter, which is called the restarting probability and it determines the probability of restarting random walk from seed genes (1−∝ is probability of going to a neighbor).
In this study, the value of ∝ value is 0.15. This algorithm iterates repeats until the difference between y and y +1 becomes less than 10 −6 (5).
NP uses network flow propagation to prioritize genes. It simulates an information pump that emanates at the seeds.
Its idea is very similar to the RWR algorithm with one difference. In the NP algorithm, output and input flows of nodes are both normalized (rows and columns are normalized) (6). After applying these algorithms, three scores are assigned to each non-seed gene.
It is rational to suppose that similar phenotypes have a common causing gene (21, 22) , and it has also been proved that the causing gene of diseases with similar symptoms have a shared interacting gene (23) . So, we used the Human Symptoms Disease Network (HSDN) (23) to find diseases with similar symptoms to CRC. In this network, nodes represent diseases and the edges are the symptom similarities between them. In the Human Symptoms Disease Network, the subscription rate between diseases and the common MeSH terms between diseases are used to weight the similarity edges. Here, we selected ten top similar diseases to CRC ( Fig. 1 ) and we extracted their causing genes from the DisGeNet database. We calculated the intersection between the causing genes of these top similar diseases and assigned these scores to each non-seed gene. For example, a gene that is associated with one disease, earns a score of one. 
Combining scores of each gene with MADM
In the previous steps, the genes received four different scores. Then we used the weighted summation to calculate the final score of each gene. The MADM technique was applied to calculate the weight of each step. In MADM, there are several possible alternatives that are evaluated according to some criteria, and they are then ranked. In this approach, we considered disease symptom similarity, RWR, NP and SP steps as alternatives that are evaluated by leave-one-out cross-validation criteria. In other words, the result of each step was assessed in leave-one-out crossvalidation analysis and some criteria were measured according to this analysis to definitively weight each step ( Finally, a weight was assigned to each step and was then ranked.
In leave-one-out cross-validation, each seed gene is removed from a seed gene set (target gene) and an artificial linkage interval is constructed on its 99 chromosomal neighbors, which are obtained from the UCSC database (24).
These 99 genes and the target gene were then considered to be the candidate set and the remaining seed genes made up the new seed set. We then applied our algorithm to this new candidate set, from which their genes were ranked according to the new seed gene set (Fig. 3) . A Receiver Operating Characteristic (ROC) curve is drawn to show the performance of a specific method with plot sensitivity versus 1-specificity. Also, an Area Under Curve (AUC) measure is calculated for each curve. Here, sensitivity is the percentage of disease genes that are ranked above a specific (k) threshold, and specificity defines the percentage of all genes ranked below the threshold (k). Also, Mean Reciprocal Rank (MRR) is obtained by using the following equation:
Here is the rank of the target gene in the ith candidate set and is the count of candidate gene sets. The other measure is an average rank (AR), which is the average rank of the target seeds in their related candidate sets.
1% and 5% are also the other criteria that represent the percentage of target genes in the top 1% and 5% of candidate sets. All these measures are reported for NP, RWR, SP and disease similarity step in Table 1 .
After calculating AUC, AR, MRR, 1% and 5% measures, we applied the Analytic Network Process (ANP) (25) method. The ANP considers the relationship and feedback between criteria in the whole system in order to compare them. So the network structure was constructed as you can see in Fig. 4 . The following order was utilized to compare the criteria and to weigh them. AUC and MRR globally assess results and thus we gave more importance to them.
Then, these criteria weights was used in the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) (26) to investigate the RWR, NP, SP and symptom similarity steps (alternatives) according to criteria. The TOPSIS method is based on the concept that the best alternatives should have the shortest distance from the positive-ideal solution and the longest distance from the negative-ideal solution. This means that, positive and negative ideal solutions are built to compare the alternatives against each other and to weigh them. We used these weights in the weighted summation to rank non-seed genes. Notably, other MADM methods are examined and the best result is found using hybrid TOPSIS-ANP, such as analytic hierarchy process (AHP) (27) , Fuzzy TOPSIS (FTOPSIS) (28), Fuzzy AHP (FAHP) (29) and FTOPSIS-FAHP methods. For a more accurate conclusion, we applied the Weighted Discounted Rating System (WDSR) (30) and the Ndimensional Order Statistics (NDOS, used in the Endeavour method) (12) to integrate the outcomes of the four aforementioned steps. These methods compose multiple ranked lists to obtain one rank. We evaluated their performance using leave-one-out cross-validation. Fig. 5 illustrates the ROC curve for each method. As can be seen, weighted summation with TOPSIS-ANP displayed a better performance than WDRS and NDOS by a significant margin.
Figure 5. Performance comparison for Heterogeneous data composition methods
Each gene was assigned four scores in our approach and we applied hybrid TOPSIS-ANP to calculate the weight of each score and then obtained the final score by weighted sumation. Also, NDOS and DRS were examined and compared with our result for more reliability.
Results and discussion
In this paper, we proposed the NRSSPrioritize method, which integrates protein complex and disease similarity knowledge to utilize the benefits of both. Diseases with similar symptoms probably have common causing genes (21, 22) , and also disease related proteins tend to have interactions with each other(1). There are 12894 genes in the PPI network, of which 1121 genes were marked as disease genes (seed genes) and we detected 91% of seed genes (1025 seed genes) in one subgraph of the PPI network. This observation reinforces the hypothesis that disease assosiated genes tend to have interaction with each other in the protein levels. Additionally, we applied the MannWhitney U-test to the GSE32323 dataset, which was obtained from the GEO database (31) and observed that 449 of the seeds have significant differential expressions. NP and RWR algorithms utilitize network global information to calculate the proximity between disease genes and other genes, and the SP algorithm relies on local network characteristics. These three methods are separately applied to the PPI network in order to conquer the disadvantage of local and global methods. İt may seem that the simultaneous usage of NP and RWR is useless, but we observed that comparing their scores overcame all performance measures. Finally, all aformentioned information was integrated with weighted summation based on the hybrid TOPSIS-ANP method. NRSSPrioritize was evaluated and compared to other prioritization tools such as Endeavour, ToppGene and DIR, which use multiple data sources to prioritize disease candidate genes. We used ROC analysis to compare various methods (shown in Fig. 6 ). Additionally in 26% of the cases, NRSSPrioritize ranked the target gene as the first of a candidate gene set and in 54% of the cases, target genes were in a 1 to 5 ranking of the candidate sets. The AR of our method was the lowest amon for all examined algorithms. AR, 1% and 5% measures are shown in Table 2 for all prioritization methods.
Overall, all measures showed that our method displayed a better performance in comparison to the other previously examined algorithms. 
Conclusion
We applied RWR, NP and SP algorithm separately to the PPI network. Then, we scored genes based on disease similarity knowledge. We combined these four scores by weighted summation. We used the TOPSIS-ANP MADM method to calculate the weight of each score. With this strategy, we combined protein complexity information with specialized disease knowledge. Also, NP, SP and RWR are network-based methods and using them at same time led to decreasing the noise of the PPI network. Our achievements prove that considering various characteristics of genes is important in disease gene identification and that we can overcome the disadvantages of existing methods by combining different types of knowledge. 
